Quantitative structure-activity relationship (QSAR) of indoloacetamides as inhibitors of human isoprenylcysteine carboxyl methyltransferase.

about

A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells.

P2860

Q33330582-EAEE1CCB-F596-41D7-84BE-32DC993453A9

P2860

Quantitative structure-activity relationship (QSAR) of indoloacetamides as inhibitors of human isoprenylcysteine carboxyl methyltransferase.

Item

http://www.wikidata.org/entity/Q35928477

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Quantitative structure-activit ...... ne carboxyl methyltransferase.

@ast

Quantitative structure-activit ...... ne carboxyl methyltransferase.

@en

type

Item

label

Quantitative structure-activit ...... ne carboxyl methyltransferase.

@ast

Quantitative structure-activit ...... ne carboxyl methyltransferase.

@en

prefLabel

Quantitative structure-activit ...... ne carboxyl methyltransferase.

@ast

Quantitative structure-activit ...... ne carboxyl methyltransferase.

@en

P1476

Quantitative structure-activit ...... ne carboxyl methyltransferase.

@en

P2093

Jo-Lene Leow

http://www.w3.org/2001/XMLSchema#string

Mei-Lin Go

http://www.w3.org/2001/XMLSchema#string

Patrick J Casey

http://www.w3.org/2001/XMLSchema#string

Rudi Baron

http://www.w3.org/2001/XMLSchema#string

P2860

Posttranslational modification of the Ha-ras oncogene protein: evidence for a third class of protein carboxyl methyltransferases

Targeting Ras signaling through inhibition of carboxyl methylation: an unexpected property of methotrexate

Analysis of the kinetic mechanism of recombinant human isoprenylcysteine carboxylmethyltransferase (Icmt)

Endoplasmic reticulum membrane localization of Rce1p and Ste24p, yeast proteases involved in carboxyl-terminal CAAX protein processing and amino-terminal a-factor cleavage

Protein prenyltransferases

Amide-substituted farnesylcysteine analogs as inhibitors of human isoprenylcysteine carboxyl methyltransferase.

A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells.

Perspectives on farnesyl transferase inhibitors in cancer therapy.

Prenyl-binding domains: potential targets for Ras inhibitors and anti-cancer drugs.

Farnesyltransferase inhibitors as anticancer agents: critical crossroads.

P304

1025-1032

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BMCL.2006.11.030

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6642587

http://www.w3.org/2001/XMLSchema#string

P698

17157012

http://www.w3.org/2001/XMLSchema#string

P932

1941685

http://www.w3.org/2001/XMLSchema#string

Quantitative structure-activity relationship (QSAR) of indoloacetamides as inhibitors of human isoprenylcysteine carboxyl methyltransferase.

about

P2860

P2860

Quantitative structure-activity relationship (QSAR) of indoloacetamides as inhibitors of human isoprenylcysteine carboxyl methyltransferase.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932